KOREA PHARMA Co., Ltd. (032300) Price & Analysis

― Followers

032300 Stock Chart & Stats

$7450.00

-$60.00(-0.80%)

Jul 27, 2026

―

Day’s Range― - ―

52-Week Range$7,140.00 - $15,090.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩81.91B

Enterprise Value$131.39K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.32

Next Earnings

Aug 18, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)62.57

Shares Outstanding10,906,701

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

032300 FAQ

What was KOREA PHARMA Co., Ltd.’s price range in the past 12 months?

KOREA PHARMA Co., Ltd. lowest stock price was $7140.00 and its highest was $15090.00 in the past 12 months.

What is KOREA PHARMA Co., Ltd.’s market cap?

KOREA PHARMA Co., Ltd.’s market cap is ₩81.91B.

When is KOREA PHARMA Co., Ltd.’s upcoming earnings report date?

KOREA PHARMA Co., Ltd.’s upcoming earnings report date is Aug 18, 2026 which is in 21 days.

How were KOREA PHARMA Co., Ltd.’s earnings last quarter?

KOREA PHARMA Co., Ltd. released its earnings results on May 15, 2026. The company reported $62.574 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is KOREA PHARMA Co., Ltd. overvalued?

According to Wall Street analysts KOREA PHARMA Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does KOREA PHARMA Co., Ltd. pay dividends?

KOREA PHARMA Co., Ltd. does not currently pay dividends.

What is KOREA PHARMA Co., Ltd.’s EPS estimate?

KOREA PHARMA Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does KOREA PHARMA Co., Ltd. have?

KOREA PHARMA Co., Ltd. has 10,906,701 shares outstanding.

What happened to KOREA PHARMA Co., Ltd.’s price movement after its last earnings report?

KOREA PHARMA Co., Ltd. reported an EPS of $62.574 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.955%.

Which hedge fund is a major shareholder of KOREA PHARMA Co., Ltd.?

Currently, no hedge funds are holding shares in KR:032300

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology